Posts Tagged ‘Biotech’
The Swiss Health Valley Shines with Multiple Innovation Awards
The Swiss Health Valley continues to demonstrate its strength as a European powerhouse in life sciences, medtech, and biotechnology. In recent weeks, several startups and innovators from our ecosystem have been honoured with prestigious awards, highlighting the region’s exceptional dynamism and creativity. MoleSense wins the Swiss Innovation Challenge Before an audience of nearly 4,000 people,…
Read MoreWomen Scientists Shaping the Future of Health and Science in the Swiss Health Valley
From neurology to nanotechnology, and from molecular biology to cancer immunology, women scientists across the Swiss Health Valley are driving discovery, innovation, and impact.
Read MoreUCB Farchim Invests Over CHF 100 Million and Creates 80 New Jobs in Bulle
UCB Farchim, the Swiss subsidiary of Belgian biopharmaceutical group UCB, has announced a major new phase of development for its Bulle (Fribourg) site, with more than CHF 100 million in new investments and the creation of 80 additional jobs by 2030. Since opening in 1996, UCB has invested nearly CHF 700 million in its…
Read MoreBioscibex Receives CHF 150,000 from Venture Kick
EPFL spin-off Bioscibex, a biotechnology start-up specialising in bioproduction equipment, has secured CHF 150,000 in funding from Venture Kick. This fundraising will accelerate the market launch of Swingo, its first single-use bioreactor, designed to simplify and automate cell culture and thus make biological therapies more accessible. Biologics have transformed the treatment of cancer, autoimmune…
Read MoreAdaptyv Raises CHF 6,40 million to Accelerate AI-Driven Protein Validation
Vaud-based startup Adaptyv, specializing in the experimental validation of AI-generated proteins, has raised CHF 6,40 million in seed funding. The round was led by Ace Ventures with participation from ByFounders, Founderful, LongGame, and several individual investors. At the same time, the company announced the public launch of its fully automated cloud laboratory platform, now…
Read MoreORYL Photonics Closes its Series A Round
ORYL Photonics announces the successful closing of its Series A round. The amount was not disclosed. The round was backed by existing shareholders. Their investment commitment has been achieved in record time (two weeks!). This milestone marks a major step forward for the fast-growing Swiss biotool company, which is pioneering advanced solutions for measuring the…
Read MoreEva.J and Bioressant: Pioneering Swiss Neurocosmetics Through Scientific Innovation
In the sophisticated landscape of contemporary skincare, where scientific rigor meets holistic wellness, Swiss company Bioressant and its flagship brand Eva.J Swiss Organic Neurocosmetics stand as exemplars of innovation at the convergence of neuroscience, dermatology, and biotechnology. Founded by Eva Johnston in Lausanne, this pioneering enterprise has established itself as a trailblazer in the emerging…
Read MoreInkocell Therapeutics secures CHF 150,000 from Venture Kick
EPFL spin-off Inkocell Therapeutics, a Swiss biotech startup developing next-generation cell therapies, has secured CHF 150,000 from Venture Kick. The funding will accelerate the development of Inkocell’s first-in-class NK-tailored CAR (chimeric antigen receptor) technology, designed to create effective, safe, off-the-shelf, and affordable therapies for patients with life-threatening diseases. Over the past decade, engineered T-cell…
Read MoreInnosuisse Supports 7 Promising Swiss Health Valley Startups
Innosuisse has selected 39 new Startup Innovation Projects, providing direct funding to early-stage Swiss companies on the cusp of entering the market. These startups are driving innovation across diverse sectors, from pharma and life sciences to industrial applications and beyond. 7 are located in the Swiss Health Valley. Through its Startup Innovation Projects programme,…
Read MoreHevelion, IRIS and Kymansis awarded by the FIT
The Fondation pour l’Innovation Technologique awards three life sciences projects from CHUV and EPFL: Hevelion from UNIL-CHUV, and IRIS and Kymansis from EPFL. They received CHF 100’000 Tech Grants to continue developing their technologies. Hevelion: spatial omics for new targeted therapies Hevelion is developing an AI-powered software platform to accelerate spatial biomarker discovery for…
Read More